US Capitol Capsule: Taking aim at cost reductions, Senate panel chief puts bull's-eye on biopharma
25 July 2011
Donna Young
Please Login to read the full article.
25 July 2011
Donna Young
Please Login to read the full article.
RELATED CONTENT
NEWS
- Congressional analysis: Pay-for-delay ban would save taxpayers $4.8B over 10 years
- US Capitol Capsule: Use of mind-altering medicines in children, elderly under fire
- FTC: authorized generics benefit consumers, but sometimes used as threat to competitors
- US Capitol Capsule: PhRMA hopes Part D savings will be muscle against 'Super Congress' cuts
ANALYSIS
Other Informa Analysis
EVENTS
Today
The Rembrandt Hotel, London
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
